Evidence map›Paper›PMID 32026311›Full record

ArticleInfection2020

Setting an appropriately high enough bar when evaluating the safety of antiretroviral drugs for use in pregnancy.

Kathleen M Powis, Amy L Slogrove

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kathleen M PowisDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. kpowis@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-4478-4471
Amy L SlogroveDepartment of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Worcester, South Africa.

Funding

The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South AfricaK43TW010683 · FIC · STELLENBOSCH UNIVERSITY · PI SLOGROVE, AMY LOUISE · 2017 to 2021
$647k
INFORM - AIDS FREE: A Harmonized Infrastructure For Monitoring Health Outcomes of the "AIDS FREE Generation"R21HD093531 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI POWIS, KATHLEEN · 2018 to 2019
$409k
Collaborative Initiative for Pediatric HIV Education and Research (CIPHER) 2017/518-SLOFIC NIH HHS K43 TW010683FIC NIH HHS K43TW010683National Institute of Child Health and Human Development R21HD093531NICHD NIH HHS R21 HD093531
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV-1HIV InfectionsFemaleHumansInfant, NewbornInfectious Disease Transmission, VerticalIntegrase InhibitorsIntegrasesPregnancyProtease InhibitorsReverse Transcriptase InhibitorsIntegrase InhibitorsIntegrasesProtease InhibitorsReverse Transcriptase Inhibitors

Identifiers

PMID32026311
PMCPMC7103493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.